Company: RILYN
Filing Date: 2025-11-18
Form Type: 10-Q
Source: 0001464790-25-000023
Chunk: 161

Company: B. Riley Financial, Inc.
Filing Date: 2025-11-18
Form: 10-Q
Item: Part I, Item 2
Chunk 161
---
 decreased $34.7 million to $0.7 million during the three months ended March 31, 2025 from $35.4 million for the three months ended March 31, 2024. The decrease was due to a decrease in the securities loaned and loan participations sold balances from $2.0 billion as of March 31, 2024 to $33.0 million as of March 31, 2025.

Other Income (Expense). Other income included interest income of $1.5 million and $0.7 million during the three months ended March 31, 2025 and 2024, respectively. Dividend income was $0.1 million during the three months ended March 31, 2025 compared to $3.0 million during the three months ended March 31, 2024. 

  79                                                                                                                                  

Realized and unrealized losses on investments was a loss of $14.5 million during the three months ended March 31, 2025 compared to a loss of $34.9 million during the three months ended March 31, 2024, which is comprised of the following: 

Realized and Unrealized Gains (Losses)Three Months EndedMarch 31,20252024Other income (Expense) - Realized & Unrealized Gains (Losses)Public Equity Securities:Babcock & Wilcox Enterprises, Inc. - common stock$(11,488)$(4,875)Babcock & Wilcox Enterprises, Inc. - preferred stock(462)276 Alta Equipment Group, Inc. - common stock— (3,537)Double Down Interactive Co., Ltd - common stock(2,077)14,147 Synchronoss Technologies, Inc. - common stock— 2,520 LifeMD, Inc. - Common Stock— (1,015)Other public equities(208)2,204 Subtotal(14,235)9,720 Private Equity Securities:Freedom VCM Holdings, LLC— (32,655)Kanaci Technologies, LLC— (7,096)CSL Completions Co-Invest-A, LLC— (11,541)Other private equities(1,622)6,223 Subtotal(1,622)(45,069)Corporate bonds1,357 467 Partnership interest and other— (42)Total$(14,500)$(34,924